Patent · US Active

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

US10577318B2 · kind B2 · utility

0Cited by

5References

1Claims

0Family size

Assignee

EPICS THERAPEUTICS · BE

Inventors

Hamid R. Hoveyda · Brussels, BE
Didier Schils · Loupoigne, BE
Ludivine Zoute · Vedrin, BE
Julien Parcq · Lille, FR

Key dates

Filing date	Jun 18, 2019
Grant date	Mar 3, 2020
Priority date	—
Expiry date	Jun 18, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel intermediates of the formula E: which are useful in the synthesis of agonists of g-protein coupled receptor 43 for treating and/or preventing metabolic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.